Patents by Inventor Sumner Burstein

Sumner Burstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lipid-amino acid conjugates and methods of use
    Publication number: 20060014820
    Abstract: N-fatty acid-amino acid conjugates and J2 prostanoid-amino acid conjugates are disclosed along with methods for making such conjugates and methods of using these conjugates in the treatment of conditions that involve dysfunctional lipid metabolism, insulin sensitivity, glucose homeostasis, and/or inflammation.
    Type: Application
    Filed: July 15, 2005
    Publication date: January 19, 2006
    Inventors: Sumner Burstein, Robert Zurier
  • Methods for decreasing cell proliferation based on (3r,4r)-?8-tetrahydrocannabinol-11-oic acids
    Patent number: 6974835
    Abstract: The invention relates to the use of cannabinoid compounds (derivatives of tetrahydrocannabinol) for decreasing cell proliferation in a mammal.
    Type: Grant
    Filed: May 17, 2001
    Date of Patent: December 13, 2005
    Assignee: Indevus Pharmaceuticals, Inc.
    Inventors: Sumner Burstein, Lawrence Recht, Robert B. Zurier
  • Cannabinoid drugs
    Patent number: 6914072
    Abstract: The invention relates to the use of cannabinoid compounds (derivatives of tetrahydrocannabinol) for decreasing cell proliferation in a mammal.
    Type: Grant
    Filed: May 17, 2001
    Date of Patent: July 5, 2005
    Assignee: Indevus Pharmaceuticals, Inc.
    Inventors: Sumner Burstein, Lawrence Recht, Robert B. Zurier
  • Platelet activating factor antagonist and methods of use therefor
    Patent number: 4973603
    Abstract: 6a,7,10,10a-tetrahydro-6,6-dimethyl-9-carboxyl-3-pentyl-6-H-dibenzo [b,d] pyran-1-ol is a potent antagonist to endogenous platelet activating factor (PAF). PAF is a factor in many of the pathological manifestations of disease, allergy or injury, such as inflammation, thrombosis and anaphylaxis. The actions of PAF can be inhibited in vivo by the present composition, thereby providing a safe and effective treatment for PAF-induced disorders.
    Type: Grant
    Filed: May 11, 1989
    Date of Patent: November 27, 1990
    Inventor: Sumner Burstein
  • Delta 1-thc-7-oic acid and analgesic and anti-inflammatory agents
    Patent number: 4847290
    Abstract: A non-psychoactive metabolite of THC is described. The invention is based on the discovery that this metabolite has analgesic and anti-inflammatory properties. The use of the metabolite as a therapeutic agent is based upon the further discovery that it is non-ulcerogenic.
    Type: Grant
    Filed: August 17, 1987
    Date of Patent: July 11, 1989
    Inventor: Sumner Burstein